PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:29 AM ET

Sponsor Check › Person

DD
No photo found yet (own website and image search run after this page is viewed)

David Dantzker

Named as an officer, director or promoter on SEC Form D filings · NY, NJ · Apr 8, 2013 → Oct 17, 2023

2deals (issuers)
$3.77Mreported sold
44investors
11Form D filings
2013–2023years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:28 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

David Dantzker is listed as an executive officer and director on 11 SEC Form D filings by 2 issuers between Mar 2012 and Dec 2024: Oligomerix, Inc. (White Plains, NY — pharmaceuticals — 2012–2024; $2.44M reported sold to 12 investors) and Origin Life Sciences, Inc. (Princeton, NJ — biotechnology — 2013–2023; $1.33M reported sold to 32 investors).

What this means 2 separate companies raised money with this person listed as executive officer and director, over about 12 years. Across those companies the filings report $3.77M sold in total.

Listed alongside Victor Micati (7 shared filings), Michael David Preston (6 shared filings), Douglas Durand (5 shared filings), Jack Pasini (5 shared filings), James Moe (5 shared filings) and 17 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 11 public filings for David Dantzker and found 10 differences, 1 worth asking the sponsor about: 4 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for David Dantzker has not run yet — it is joining a line of 17,643 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:28 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched David Dantzker..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:28 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

10 differences found between the filings for David Dantzker — 1 worth asking about (compared 11 filings on Oct 24, 2026)

Worth asking · Mar 22, 2013 – Oct 17, 2023

4 Form Ds were filed more than 15 days after the first sale

Form D filed 69 days after the first sale — Origin Life Sciences, Inc. · Form D filed 129 days after the first sale — Origin Life Sciences, Inc. · Form D filed 60 days after the first sale — Origin Life Sciences, Inc. · Form D filed 17 days after the first sale — Origin Life Sciences, Inc.

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Sources
Note · Apr 8, 2013 – May 15, 2017

David Dantzker's role changed at Origin Life Sciences, Inc.: director → executive officer, director

The Apr 8, 2013 filing lists David Dantzker as director; the May 15, 2017 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · Mar 22, 2013 – Dec 6, 2024

8 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Oligomerix, Inc. (latest filing Dec 6, 2024) · No amendment in the last 12 months on an offering that may still be open — Origin Life Sciences, Inc. (latest filing Oct 17, 2023) · No amendment in the last 12 months on an offering that may still be open — Origin Life Sciences, Inc. (latest filing Jun 22, 2023) · No amendment in the last 12 months on an offering that may still be open — Origin Life Sciences, Inc. (latest filing Sep 7, 2022) · No amendment in the last 12 months on an offering that may still be open — Oligomerix, Inc. (latest filing Mar 29, 2022) · and 3 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Sources
Note · Mar 20, 2012 – Apr 8, 2013

David Dantzker is written 2 different ways on the filings

listed as "David Dantzker" on 9 filings (from Mar 20, 2012), and "David Dantzker, MD" on 2 filings (from Apr 8, 2013).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Sources
Note · Nov 4, 2009 – Mar 26, 2010

Same name, different state: "David Dantzker" (CA) is a separate record

This page covers filings where the address state is NY or NJ. A separate record, "David Dantzker" with address state CA, is listed on 2 filings — most recently by NovaRay Medical, Inc. (Mar 26, 2010). The two records do not overlap in time: this page runs Apr 8, 2013 to Oct 17, 2023; the other runs Nov 4, 2009 to Mar 26, 2010.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Apr 15, 2015 – Mar 29, 2022

Address moved from New York, NY to White Plains, NY — Oligomerix, Inc.

The people listed on the Apr 15, 2015 filing give New York, NY; on the Mar 29, 2022 filing they give White Plains, NY.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Apr 8, 2013 – May 15, 2017

Address moved from Lawrenceville, NJ to Princeton, NJ — Origin Life Sciences, Inc.

The people listed on the Apr 8, 2013 filing give Lawrenceville, NJ; on the May 15, 2017 filing they give Princeton, NJ.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Mar 20, 2012 – Dec 6, 2024

David Dantzker is listed with 2 different address states: NY, NJ

NY on 5 filings (Mar 20, 2012 to Dec 6, 2024); NJ on 6 filings (Apr 8, 2013 to Oct 17, 2023).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
Note · Apr 8, 2013 – Jun 1, 2023

Reported revenue range changed between filings — Origin Life Sciences, Inc.

"No Revenues" (Apr 8, 2013); then "Decline to Disclose" (Jun 1, 2023).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Sources
Note · Jun 1, 2023 – Jun 22, 2023

Minimum investment changed between filings — Origin Life Sciences, Inc.

The Jun 1, 2023 filing lists a minimum of $25,000; the Jun 22, 2023 Form D/A lists $5,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

4 of 10 offerings report sales commissions totalling $214,742; 0 report finder's fees; 4 report proceeds to related persons totalling $1,184,450. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Dec 6, 2024 D
Oligomerix, Inc.
File 021-531375
$0$0$0None listed on this filingEDGAR ↗
Oct 17, 2023 D
Origin Life Sciences, Inc.
File 021-495034
$3,570$0$0
While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers.
Boustead Securities, LLC BrokerCheck CRD 141391 ↗EDGAR ↗
Jun 22, 2023 D/A
Origin Life Sciences, Inc.
File 021-483151
$46,172$0$0
While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers.
Boustead Securities, LLC BrokerCheck CRD 141391 ↗EDGAR ↗
Sep 7, 2022 D
Origin Life Sciences, Inc.
File 021-458259
$40,000 (est.)$0$0 (est.)BOUSTEAD SECURITIES, LLC BrokerCheck CRD 141391 ↗EDGAR ↗
Mar 29, 2022 D
Oligomerix, Inc.
File 021-439346
$0$0$650,000 (est.)None listed on this filingEDGAR ↗
May 15, 2017 D
Origin Life Sciences, Inc.
File 021-286771
$0 (est.)$0$0 (est.)
A portion of the proceeds will be used to pay accrued management fees and executive salaries.
None listed on this filingEDGAR ↗
Apr 15, 2015 D
Oligomerix, Inc.
File 021-238005
$0$0$200,000 (est.)None listed on this filingEDGAR ↗
Apr 8, 2013 D
Origin Life Sciences, Inc.
File 021-194651
$125,000 (est.)$0$0 (est.)
A portion of the proceeds will be used to pay accrued management fees and executive salaries.
None listed on this filingEDGAR ↗
Feb 14, 2013 D
Oligomerix, Inc.
File 021-191896
$0$0$240,000 (est.)None listed on this filingEDGAR ↗
Mar 20, 2012 D
Oligomerix, Inc.
File 021-175258
$0$0$94,450 (est.)None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 2

Every issuer that named David Dantzker on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Pharmaceuticals

Oligomerix, Inc.

White Plains, NY · Mar 20, 2012 → Dec 6, 2024 · 5 filings
  • Dec 6, 2024 · D · $75,000 sold of $650,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 29, 2022 · D · $2,440,568 sold of $3,500,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 15, 2015 · D · $400,000 sold of $3,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 14, 2013 · D · $0 sold of $2,800,000 · 0 investors · min. $20,000 · role: Director EDGAR ↗
  • Mar 20, 2012 · D · $0 sold of $2,700,000 · 0 investors · min. $25,000 · role: Director EDGAR ↗

Raised $2.44M from 12 investors (100% of the $650K target) as of the latest filing. David is listed as director on 5 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Origin Life Sciences, Inc.

Princeton, NJ · Apr 8, 2013 → Oct 17, 2023 · 6 filings
  • Oct 17, 2023 · D · $51,000 sold of $5,000,000 · 2 investors · min. $1,000 · role: Executive Officer, Director (Chief Medical Officer) EDGAR ↗
  • Jun 22, 2023 · D/A · $659,600 sold of $850,000 · 6 investors · min. $5,000 · role: Executive Officer, Director (Chief Medical Officer) EDGAR ↗
  • Jun 1, 2023 · D · $500,000 sold of $850,000 · 1 investors · min. $25,000 · role: Executive Officer, Director (Chief Medical Officer) EDGAR ↗
  • Sep 7, 2022 · D · $500,000 sold of $5,000,000 · 7 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • May 15, 2017 · D · $1,332,100 sold of $22,500,000 · 32 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Apr 8, 2013 · D · $500,000 sold of $2,500,000 · 1 investors · min. $50,000 · role: Director EDGAR ↗

Raised $1.33M from 32 investors (27% of the $5M target) as of the latest filing. David is listed as executive officer, director on 6 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • David Dantzker — CA, 1 issuer, Nov 4, 2009 → Mar 26, 2010 · no shared issuer

People around David 22

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

VM
No photo found yet (own website and image search run after this page is viewed)
Person

Victor Micati

Director · 7 shared filings (2 issuers)

Listed on the same filings as David Dantzker. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Michael David Preston

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

DD
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas Durand

Director · 5 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

Jack Pasini

Director, Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

James Moe

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

HN
No photo found yet (own website and image search run after this page is viewed)
Person

Howard Nelson

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey Bluestein

Director · 3 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

John Fernandes

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

Jerome Boda Korten

Director · 3 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony Brampton

Director · 3 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

AP
No photo found yet (own website and image search run after this page is viewed)
Person

Alex Dolgopolsky, PhD

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

TB
No photo found yet (own website and image search run after this page is viewed)
Person

Tony Brampton

Director · 2 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

Johnny Fernandes

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

VM
No photo found yet (own website and image search run after this page is viewed)
Person

Vic Micati

Director · 2 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

WE
No photo found yet (own website and image search run after this page is viewed)
Person

William Erhardt

Director, Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

ED
No photo found yet (own website and image search run after this page is viewed)
Person

Eliot Davidowitz

Director, Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Pohl

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

IA
No photo found yet (own website and image search run after this page is viewed)
Person

Issac Anthony III

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

BH
No photo found yet (own website and image search run after this page is viewed)
Person

Betsy Hanna

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Forester

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Mike Pohl

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Foerster

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as David Dantzker. Their page shows their other deals.

Registrations and other filings

Adviser registration (Form ADV)

None of the 2 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to David Dantzker by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 2 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers David Dantzker is listed on: none on file. No website or social profile named in Origin Life Sciences, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #115,479 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Princeton, NJ). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when David Dantzker appears on a new Form D, or when a court case or SEC action is matched to them. See plans →